Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells.
| Autor: | Wu, W. K. K.1,2,3, Sung, J. J. Y.1,3, Wu, Y. C.2,4, Li, Z. J.2, Yu, L.2, Cho, C. H.2,3 chcho@cuhk.edu.hk |
|---|---|
| Zdroj: | British Journal of Pharmacology. Jun2008, Vol. 154 Issue 3, p632-638. 7p. 2 Black and White Photographs, 4 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|